Saccharomyces cerevisiae-derived vesicles loaded with dextromethorphan as a candidate for the management of neuroinflammation related to Alzheimer’s disease.

Bibliographic Details
Title: Saccharomyces cerevisiae-derived vesicles loaded with dextromethorphan as a candidate for the management of neuroinflammation related to Alzheimer’s disease.
Authors: Valizadeh, Parastoo1,2 (AUTHOR), Mozafari, Negin2 (AUTHOR), Ashrafi, Hajar2 (AUTHOR), Heidari, Reza3 (AUTHOR), Azarpira, Negar4 (AUTHOR), Azadi, Amir2,3 (AUTHOR) aazadi@sums.ac.ir
Source: Pharmaceutical Development & Technology. Feb2025, p1-9. 9p. 6 Illustrations.
Subject Terms: Central nervous system injuries, Targeted drug delivery, Drug delivery systems, Particle size distribution, Encephalitis
Abstract: AbstractAlzheimer’s disease (AD) is a neurodegenerative disease that is associated with neuroinflammation. Dextromethorphan (DXM) exerts neuroprotective effects in many central nervous system injuries and neurodegenerative diseases. The cell wall of Saccharomyces cerevisiae is a cell-based drug delivery system that can be a suitable candidate for targeted drug delivery to the site of inflammation. In this study, nanoparticles (NPs) were prepared from Saccharomyces cerevisiae cell walls, coated with polysorbate-80, and loaded with DXM. NPs had favorable hemolytic behavior with a particle size distribution of 187.25 ± 73.37 nm and a zeta potential of +4.3 mV. Pathological examination in a mouse model of neuroinflammation showed that NPs had the ability to reduce brain inflammation and the adverse effects of DXM. [ABSTRACT FROM AUTHOR]
Copyright of Pharmaceutical Development & Technology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Business Source Complete
More Details
ISSN:10837450
DOI:10.1080/10837450.2025.2470351
Published in:Pharmaceutical Development & Technology
Language:English